Browse Articles
Discover research articles across all indexed journals
Real-world artificial intelligence use in oncology practice: High clinician verification amid critical governance gaps.
353 Background: Artificial intelligence (AI) tools are rapidly entering oncology practice. However, real-world data describing how clinicians use AI—particularly outside institution-approved systems—remain limited. Characterizing adoption, verification, and responsibility is essential for safe implementation. Methods: We conducted a voluntary, anonymous cross-sectional survey of U.S. oncology clinicians assessing real-world AI use. Domains included clinician characteristics, institutional access, independent AI use, verification behavior, governance, and responses to a standardized clinical scenario. Descriptive statistics were performed. Results: Thirty-one clinicians completed the survey, including hematology–oncology fellows (45%) and attending oncologists (29%), across academic and community settings. Despite limited institutional access, 97% reported independent clinical AI use. Over 80% consistently removed patient identifiers prior to use. AI literacy was high, with recognition of probabilistic outputs and limited generalizability. When AI conflicted with clinical judgment, 87% always or usually independently verified outputs. In a standardized scenario, confidence in AI recommendations varied widely. Responsibility for AI-related errors was attributed to clinicians alone or shared with institutions and vendors. Notably, 68% reported no clear institutional policies governing AI in clinical workflows. Conclusions: Clinicians are integrating AI largely outside formal oversight while maintaining high verification rates. These findings support the need for clinician-led governance frameworks aligning AI use with patient safety and institutional responsibility. AI governance–adoption gap in oncology practice (N = 31). Characteristic n (%) Hematology–Oncology Fellows 14 (45) Attending Medical Oncologists 9 (29) Academic Practice Setting 16 (52) Independent AI Use for Clinical Work 30 (97) Access to Approved Institutional AI Tools 13 (42) No Access or Unsure 18 (58) Clear Institutional AI Policies Exist 10 (32) No Clear AI Governance 21 (68) Using AI Without Institutional Oversight* 20 (65) *Defined as clinicians reporting either no institutional AI policies or no access to approved AI tools while using AI clinically.
Testosterone deprivation or androgen receptor inhibition effect on endothelial glycocalyx injury in prostate cancer.
193 Background: Endothelial glycocalyx, which coats the luminal surface of vascular endothelial cells, plays a pivotal role in maintaining vascular homeostasis by regulating thrombogenicity, modulating inflammatory responses, and preserving endothelial barrier integrity. Androgen deprivation therapy (ADT) and androgen receptor signaling inhibitors (ARSIs) are associated with cardiovascular risk in prostate cancer. However, their effects on endothelial glycocalyx integrity, an early determinant of endothelial dysfunction, remain unknown. We investigated whether ARSIs or ADT induce endothelial glycocalyx injury. Methods: In this retrospective study, 43 patients initiating ARSIs (enzalutamide, abiraterone acetate, apalutamide, or darolutamide) and 39 patients initiating ADT (LHRH agonists, GnRH antagonists, or combined androgen blockade) were analyzed. Plasma hyaluronan levels, a validated biomarker of endothelial glycocalyx injury, were measured before and 1 month after treatment initiation using enzyme-linked immunosorbent assay. Paired comparisons were performed using the Wilcoxon signed-rank test. Results: Plasma hyaluronan levels did not significantly change after ARSI initiation (mean 260 vs 270 ng/mL, P = 0.724). In contrast, ADT initiation was associated with a significant increase in hyaluronan levels (mean 238 vs 420 ng/mL, P = 0.009). No significant differences in plasma hyaluronan changes were observed between LHRH agonists and GnRH antagonists ( P = 0.816). Conclusions: Short-term ARSI therapy did not impair endothelial glycocalyx integrity, whereas ADT was associated with significant glycocalyx injury. These findings suggest that testosterone deprivation, rather than direct androgen receptor inhibition, may contribute to endothelial dysfunction during prostate cancer treatment.
Threading an Aluminum Molecular Ring Onto a Chemically Growing Copper‐Directed Polyrotaxane
ABSTRACT Controlled assembly of advanced mechanically interlocked architectures remains a major challenge in supramolecular chemistry. Inspired by the hard and soft acids and bases principle, we present a modular and hierarchical strategy for the synthesis of aluminum‐based mechanically interlocked molecules (AlMIMs) assembled from four synergistic components. Aluminum ions generate robust macrocyclic frameworks through coordination with aromatic carboxylates, while adaptive nitrogen‐donor ligands, in concert with structure‐directing copper ions, promote axle threading and govern structural dimensionality. This approach creates a full structural library, from discrete [2]‐ and [3]rotaxanes to extended polyrotaxane networks, demonstrating broad versatility. Within the spatially confined macrocyclic cavity, copper ions preferentially adopt a stable linear coordination geometry while remaining conformationally flexible outside the cavity to accommodate diverse coordination modes and aggregation states. This dual behavior cooperatively facilitates highly ordered assembly. Notably, the resulting AlMIMs exhibit remarkably enhanced third‐order nonlinear optical responses, highlighting emergent properties arising from mechanical interlocking. This work underscores the power of merging coordination chemistry with supramolecular design, transcending conventional static paradigms by revealing how metal ion coordination can be dynamically modulated within precisely engineered supramolecular environments.
Attention augmented feature fusion in a hybrid CNN–transformer for fine-grained diabetic retinopathy severity grading
Interlocking Stabilized 3D Photothermal Nano‐Architectures Enables Distributed Solar Desalination
ABSTRACT Tackling global water scarcity requires sustainable technologies that operate at the water‐energy‐food nexus. Solar‐driven evaporation is a promising approach, but its practical deployment is often hampered by the difficulty in synergistically integrating performance, robustness, and economic viability. Here, by using the intrinsic property of hollow multishelled structure (HoMS), we established a scalable strategy by interlocking the polymer molecular chain into the porous shell of HoMS, investigating an economical and faci le approach to construct three‐dimensional (3D) photothermal architectures. To achieve an abundant loading amount, we selected the solvents based on Hansen solubility parameters, achieving precise polymer threading through HoMS, leading to uniform nanomaterial loading and creating the hierarchical “nanoforest” morphology. This structure exhibits 90.2% broadband solar absorption and reduces the energy consumption of evaporation by 45.7%, achieving a record‐high evaporation rate of 38.14 ± 0.57 kg m −2 h −1 with year‐long stability. We integrated this material into a 0.75 m 2 active‐condensation solar desalination device, which produces 20.16 L of freshwater per day under natural sunlight, meeting WHO drinking standards. The produced water successfully supported the full‐growth cycles of various crops in a 5 m 2 demonstration plot with lower cost. Our work provides a feasible and sustainable route for solar‐driven water solutions.
Cerebral Cortex Inspired Bio‐Interface Engineering: Fast Zn Ions Reaction Kinetics for Low‐Temperature Energy Storage
ABSTRACT Carbon‐based aqueous zinc‐ion batteries (CAZBs) require stable operation under extremely low temperatures for practical applications, but they are hindered by sluggish Zn 2 + transport within the diffusion layer and desolvation barriers in the Helmholtz layer. Here, a bio‐inspired interface engineering strategy—derived from the high‐volume, high‐speed, and high‐efficiency signal processing capability of the cerebral cortex—is employed to construct hierarchical carbon spheres with sulcus–gyrus architectures (HCSs‐sg). Such HCSs‐sg can effectively imitate the dense neuron distribution in the cerebral cortex and lead to a sharp increase in pseudocapacitive active sites. This biomimetic configuration generates directional micro‐electric fields and ionic concentration gradients, which synergistically accelerate Zn 2 + transport through diffusion‐driven migration and coulombic forces. Simultaneously, the high‐curvature sulcus–gyrus exhibits enhanced Zn 2 + adsorption energy and reduced desolvation barriers, thereby facilitating efficient desolvation and rapid charge transfer at subzero temperatures. As a result, the optimized product delivers a specific capacity of 70 mAh g − 1 at 0.1 A g − 1 under −25°C and maintains a stable coulombic efficiency of nearly 100% over 10 000 cycles at 1 A g − 1 . This biomimetic interface engineering approach can provide a potential design route for aqueous battery applications under extreme‐temperature conditions.
CAR-NK cell therapy in colorectal cancer: A systematic review of early clinical signals and translational strategies.
79 Background: Colorectal cancer (CRC) demonstrates limited responsiveness to current immune checkpoint inhibitors and breakthrough in chimeric antigen receptor–T cell (CAR-T) strategies face barriers in solid tumors. CAR–natural killer (CAR-NK) therapy offers potential advantages in safety and allogeneic scalability, yet the development of CRC-directed CAR-NK therapies remains unclear. We conducted a systematic review to define clinical signals and characterize translational engineering strategies of CAR-NK in CRC. Methods: A systematic search of PubMed, Scopus, ScienceDirect, Cochrane, and Wiley Online Library was conducted from inception through February 2026 (PROSPERO CRD420261324246). We included clinical studies administering CAR-NK therapy to patients with CRC, preclinical investigations evaluating CAR-NK platforms in CRC models, and registry-based trials permitting CRC enrollment were analyzed separately. Risk of bias was assessed using ROBINS-I and the SYRCLE risk of bias tool. Results: The available evidence was limited and early-stage, with only a small number of CRC clinical studies (<15 patients) complemented by a larger body of preclinical investigations and pan–solid tumor trials permitting CRC enrollment. Clinically, CAR-NK administration, including intraperitoneal mRNA-electroporated NKG2D CAR-NK and allogeneic NKG2D CAR-NK expressing membrane-bound IL-15 ± PD-1 blockade, was feasible and well tolerated, with no reported grade ≥3 cytokine release syndrome or neurotoxicity. Locoregional tumor control and immune activation were observed. However, durable systemic responses were infrequent. Combination therapy demonstrated enhanced immune activation compared with CAR-NK monotherapy. Registry analysis identified only one CRC-dedicated CAR-NK trial. Most active studies enroll CRC within basket designs rather than disease-specific cohorts. The termination of a MICA/B-directed CAR-NK program further highlights the limited and evolving clinical development landscape in CRC. Preclinical models demonstrated consistent antigen-dependent cytotoxicity across multiple CRC targets. Convergent engineering strategies addressed trafficking, microenvironmental resistance, antigen density, and persistence, with combination approaches outperforming monotherapy in xenografts. Conclusions: CRC-specific CAR-NK evidence remains promising, with signals of safety and localized activity but limited systemic efficacy. In contrast, preclinical innovation demonstrates strategic convergence toward multi-layer engineering and rational combination design. Dedicated CRC-focused trials are urgently needed to translate these advances into clinically meaningful outcomes.
Clinicopathologic features, treatment patterns, and survival outcomes of glycogen-rich clear cell carcinoma of the breast: A National Cancer Database Analysis.
40 Background: Glycogen-rich clear cell carcinoma (GRCC) of the breast is rare subtype of invasive breast carcinoma, characterized by the presence of neoplastic cells with a glycogen-abundant clear cytoplasm. Due to the rarity of this disease, existing literature is limited to case reports and limited case series with conflicting data regarding clinicopathologic features, treatment patterns, and prognosis of this subtype. Methods: The National Cancer Database (NCDB) was queried for patients with invasive GRCC of the breast between 2004 to 2023. Baseline demographic, tumor, and treatment characteristics were summarized descriptively. Overall survival (OS) was assessed using Kaplan–Meier analysis and compared using log-rank tests. Multivariable Cox proportional hazards regression was performed to evaluate independent associations with OS. Statistical significance was defined as p<0.05. Results: A total of 132 patients with GRCC were identified. The median age at diagnosis was 61 years (interquartile range [IQR] 50–71), and the median tumor size was 2.0 cm (IQR 1.4–3.0). Patients were followed-up for a median duration of 85.0 months (IQR 48.9–137.9), during which 42 (31.8%) deaths occurred. Most patients presented with early-stage disease (48.8% Stage I, 41.0% Stage II, and 10.2% Stage III–IV disease), and 28.3% had node-positive disease. Surgical resection was performed in 90.9% of patients, and the most common surgical procedure was lumpectomy (40.9%). Chemotherapy, hormonal, and radiation therapy were administered in 63.6%, 56.8% and 56.1% of patients respectively. Of the 28 patients with available receptor data, tumors were predominantly estrogen receptor–positive (75.0%) and HER2-negative (92.9%). Surgical management (p<0.0001) and chemotherapy (p=0.004) were significantly associated with improved OS, whereas immunotherapy, hormone therapy, radiation therapy were not associated with OS. On multivariable analysis, increasing age (HR 1.04, 95% CI 1.01–1.08, p=0.020) and tumor size (HR 1.02, 95% CI 1.01–1.04, p=0.011) were significantly associated with worse OS. Surgical management remained independently associated with improved survival (HR 0.31, 95% CI 0.11–0.87, p=0.026), whereas chemotherapy was not independently associated with OS. Conclusions: In this largest study of GRCC to date, we characterize disease features, treatment patterns, and outcomes of this rare subtype. GRCC has a higher incidence in post-menopausal women, often presenting as a small primary tumor albeit with a higher likelihood of lymph node positivity and a higher mortality rate when compared to IDC as per our study. Age, tumor size, and surgical management were independently associated with OS. These findings provide valuable insight into this rare subtype that may inform management and future studies.
Surface-Immobilized Rhodium Complex in Vertically Aligned Mesoporous Silica Films for Direct Electroreduction of Diluted CO <sub>2</sub>
Highly Selective On‐Surface Synthesis of sp <sup>2</sup> /sp‐Hybridized Heterochiral Triangular Nanorings
ABSTRACT A central challenge in on‐surface synthesis of topologically unique carbon nanostructures lies in the precise and selective construction of triangular nanorings. Achieving the resulting chirality and the sp 2 /sp‐hybridized state simultaneously from prochiral precursors is critical, yet immensely difficult. Here, we design an asymmetric α‑cyanostilbene derivative with aggregation‑induced emission properties as a prochiral building block to achieve deterministic pathway selection through controlling the substrate‐ and thermal‐directed strategy, allowing for the targeted formation of heterochiral nanorings with defined sp 2 ‐ and sp‐hybridization on Ag(111). Direct thermal deposition onto a hot Ag(111) surface at 443 K drives a highly selective cyclotrimerization, yielding discrete sp 2 ‐hybridized heterochiral triangular nanorings. Subsequent annealing induces an elimination reaction, converting these rings into their sp‐hybridized analogues while preserving chirality. In contrast, room‐temperature deposition and postannealing predominantly produces linear chains. The structural evolution and selective reaction mechanisms are unequivocally characterized by scanning tunneling microscopy (STM), bond‐resolution STM, synchrotron radiation photoemission spectroscopy (SRPES), and density functional theory (DFT) calculations. This work establishes a novel strategy for the precise synthesis of chiral triangular nanorings, revealing the critical role of surface‐mediated conformational control and dynamic covalent bonding in determining product topology and chirality.
Self-compassion and earthquake fear: the mediating roles of resilience and fear of happiness
Aqueous/Alcohol‐Soluble Carbon Dot Light‐Emitting Diodes
ABSTRACT Fluorescent carbon dots (CDs), benefiting from their environmental friendliness, solution processability, tunable emission spectra, and high photoluminescence efficiency, have shown great promise for next‐generation solid‐state lighting and flat panel displays. CDs are typically synthesized via hydrothermal methods, exhibiting excellent solubility in water and alcohols. However, due to the absence of suitable alcohol‐soluble host materials, aqueous/alcohol‐soluble CDs have so far failed to achieve electroluminescence. Herein, a bipolar host material named 2PCT is specifically designed for aqueous/alcohol‐soluble CD‐based electroluminescent light‐emitting diodes (LEDs). Specifically, the introduction of donor‐acceptor units and diethyl phosphite groups enables 2PCT to have excellent bipolar transport properties and film‐forming capability. Moreover, the high solubility of 2PCT in ethanol and low production cost position it as a promising candidate for large‐scale green manufacturing of CD‐based LEDs. Using 2PCT as the host material, we have successfully fabricated multicolor (green, yellow, and red) CD‐LEDs with record‐breaking performance benchmarks among ethanol‐processed CD‐based optoelectronic devices. Benefiting from the alcohol‐compatible processing, we have further achieved air‐stable fabrication of CD‐LEDs with an extended emission area of 16 cm 2 , which holds significant potential for large‐area optoelectronic applications.
Bioinspired Ultrastretchable Aramid Triboelectric Aerogels for Intelligent Vehicle Seat
ABSTRACT Aerogels have demonstrated considerable potential in the field of flexible sensors owing to the tunability of porous architectures. The brittleness and low stretchability induced by high porosity remain key limitations restricting aerogel applications. Inspired by the orientation of muscle fibers, an ultrastretchable aramid triboelectric aerogel is developed by programmed ice crystal growth. The orientation fitting degree of the triboelectric aerogel reaches 98%, which is 2.6 times higher than that of conventional freeze‐casting methods. This ordered structure disperses tensile stresses during stretching, enabling the triboelectric aerogel to sustain an unprecedented 539% strain. Leveraging this aerogel, the triboelectric sensing array with vibration feedback was designed. Combined with deep learning algorithms, it achieved real‐time monitoring and vibration feedback alerts of driving behaviors within a single sensor interface for the first time. This study offers a promising strategy for intelligent driving systems to identify and mitigate unsafe driving behaviors.
Hallmarks based stratification of locally advanced GBC according to response to first-line chemotherapy in advanced gallbladder cancer (GBC).
309 Background: GBC is a heterogenous disease with high mortality rate. While platinum-based chemotherapy remains the SOC in advanced disease; the treatment responses are highly variable, with no tools for predictive or prognostic stratification of patients. We evaluated potential role of variable activation of cancer hallmark mechanisms inside the cancer cell, that drives disease progression, as a useful tool for upfront patient stratification. Methods: We analysed the tumor biology by CGP (TarGT Indiegene, 1212 genes) in 15 locally advanced GBC patients treated with first line cisplatin and gemcitabine. After four cycles chemotherapy, patients were stratified either as responders (R) (complete response, partial response and stable disease) or non-responders (NR) based on radiological response on CECT by RECIST criteria. For each patient, the Tumor somatic Mutations were grouped based on their potential role in different cancer hallmark mechanisms and scored as +3 (highest contribution), +2 (Moderate representation), +1 (minimal representation), 0 (no representation). Results: We observed that the molecular spectrum of responders had limited number of somatic alterations and restricted to 7 out of 10 cancer hallmarks, involving sustained proliferation, angiogenesis, genomic instability, tumor invasion and metastasis, and evasion of growth suppressors and cell death, with most hallmarks exhibiting low-to-moderate enrichment scores (1+ to 3+). Oncogenic plasticity was less aggressive with a cumulative score of <15 in most of the responders. On the other hand, the non-responders who presented with radiological progression had a broad molecular spectrum of mutations enriched in all the 10 cancer hallmarks, that resulted in a significant increase in cumulative cancer hallmark score >16 highlighting peculiar disparities between responder versus non-responders. Hallmark-based stratification score demonstrated 100% correlation with clinical outcome wherein, non-responders exhibited significantly shorter median progression free survival compared to responders (7 vs. 15 months; p=0.03). Conclusions: This is the first retrospective clinical study demonstrating the clinical utility of hallmark based molecular stratification of advanced GBC, showing significant correlation with clinical outcomes with first-line chemotherapy. High representation of tumor mutations in all 10 established cancer hallmarks, indicate clonal heterogeneity, explaining the ineffectiveness of chemotherapy in non-responder population. Further studies on large cohorts are needed to validate this finding and adopt this in prospective clinical trials.
Decision-making in cancer during pregnancy: Real-world management patterns and outcomes from Nepal.
302 Background: Cancer occurring one in every 1,000 pregnancies is rare and poses immense diagnostic and management challenges. Decision making should involve multidisciplinary approach, always considering detailed perspective into account. Evidence on real-world outcomes of multimodal treatment including surgery and systemic therapy during pregnancy in LMICs remains scarce. This study reports obstetric and oncologic outcomes of pregnancies complicated by cancer from a tertiary care center in Nepal. Methods: A descriptive study was done on patients with cancer and pregnancy attending Civil Service Hospital from January 2015 to January 2026. Clinical data were collected from hospital registry of past ten years and telephonic inquiry followed by in-person interview and thorough relevant investigations regarding their present status in terms of maternal and neonatal wellbeing. Information on demographics, cancer type, gestational age at diagnosis, treatment during pregnancy, obstetric outcomes, and maternal status at last follow-up was collected and analyzed. Results: Fifteen women had cancer with pregnancy (mean 29.7 years, range 19–35). Gestational timing at diagnosis was first trimester 3/15 (20%), second trimester 7/15 (47%), third trimester 5/15 (33%), The types of cancers: ovarian cancers (n = 4; endometrioid carcinoma-1; squamous cell carcinoma arising in dermoid cyst-1; high grade serous carcinoma-1, Krukenberg tumor secondary to primary gastric adenocarcinoma-1), chronic myeloid leukemia (CML) (n = 4), non-Hodgkin lymphoma (NHL) (n = 3), breast cancer (n = 1), CLL (n = 1), APML (n = 1) and thyroid carcinoma (n = 1). Five (33%) women terminated pregnancy before 18 weeks {leukemia: 3 [ CML (2); CLL (1)]; NHL (2)} followed by chemotherapy. Of the rest ten, delivery occurred in six [vaginal (1); cesarean section (5)]/ [term (2); preterm (4)]. No major congenital malformations documented and normal growth and development reported at follow up. Systemic therapy (including targeted agents such as imatinib or systemic chemotherapy/CHOP/ATO+ATRA where indicated) was administered in 10/15 (66%). All four cases of ovarian cancer diagnosed following surgery for adnexal masses during second trimester. None received radiotherapy during pregnancy. Except for one defaulted woman with leukemia, lost to follow up, 10/15 (66%) are currently in remission and 4/15 (27%) had died of disease. Conclusions: Cancer diagnosis and management during pregnancy is challenging, yet can be promising with a multidisciplinary team providing timely and appropriate therapy while carefully balancing the potential risks and benefits to mother and unborn fetus. These results support individualized multidisciplinary decision making and contribute real-world outcome data from a resource-limited setting to the growing evidence that carefully timed surgery and systemic therapy can be considered during pregnancy.
Effective Vacancy Regulation Simultaneously Realizes High-Performance Thermoelectric Cooling and Power Generation in n-Type PbSe Crystals
An empirical study of defect clustering in deep neural networks and its implications for testing
Correcting congenital myasthenia-associated acetylcholine receptor defects
Achieving 20.5% Efficiency in Organic Solar Cells via Co‐Crystallizable Small Molecule Acceptors
ABSTRACT Despite the remarkable efficiency enhancement enabled by the ternary strategy in organic solar cells (OSCs), yet a molecular‐level understanding of electronic coupling and its role in energetic alignment remains lacking. Here, we report a well‐defined bimolecular co‐crystal (BC) formed between the widely used acceptor L8‐BO and a newly designed benzotriazole‐based guest, Y18‐C3, as confirmed by single‐crystal x‐ray diffraction analysis. Y18‐C3 adopts a conjugated backbone similar to L8‐BO and incorporates short alkyl chains to enhance π–π stacking and extend absorption. The structural similarity between host and guest promotes strong intermolecular interactions, giving rise to pronounced intermolecular electronic coupling that enables continuous tuning of energetic alignment and absorption profiles. Consequently, D18:L8‐BO:Y18‐C3 devices exhibit enhanced molecular ordering and suppressed charge recombination, delivering a high power conversion efficiency of 20.50% with simultaneously increased short‐circuit current and fill factor while maintaining a high open‐circuit voltage. Notably, the devices achieve high performance (> 19.6%) even when the Y18‐C3 fraction reaches 50% of the total acceptor content, indicating a high tolerance to composition variations. These results highlight that constructing a BC through a shared conjugated backbone, combined with compatible intermolecular interactions and crystallization tendencies, provides an effective molecular design principle for achieving high‐performance, composition‐tolerant OSCs.
Molecular‐Interactions Driven Conjugated Polymer Nanofiber Self‐Assembly Toward Greener Fabrication
ABSTRACT Self‐assembled conjugated polymer (CP) nanofibers form elongated, percolated networks that facilitate efficient charge transport and mechanical compliance, yet a general strategy for their formation from solution remains elusive. Here, we present a molecular‐interaction‐governed framework for antisolvent‐induced nanofiber self‐assembly that couples thermodynamic fibrillar preaggregate formation with kinetic nanofiber growth. The framework integrates Hansen solubility parameters with a segment‐specific affinity descriptor to predict solvent‐antisolvent combinations for nanofiber formation. Structural characterization combined with molecular modeling shows that antisolvents with low affinity for alkyl side chains promote rigid, elongated fibrillar preaggregates, acting as key intermediates in nanofiber formation. This framework is validated across diverse solvent–antisolvent combinations and polymer systems, yielding nanofibers with tunable widths of 50–200 nm. It further enables the identification of eco‐friendly, terpene‐based solvent systems for green nanofiber manufacturing, while achieving up to threefold enhancements in field‐effect mobility. Together, these advances provide a pathway to rationally control CP nanostructures, offering broad utility for advancing sustainable, stretchable electronics.